INS and fatty liver disease: Although we found that the Rb2 treatment led to brown fat activation and browning of white fat, it is not clear which is the major and primary organ responsible for improving insulin sensitivity observed in Rb2 treated mice, especially considering previous reports recording the beneficial effects of Rb2 in improving hepatic steatosis.